Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-2-26
pubmed:abstractText
Cell replacement therapies for neurodegenerative diseases, using multipotent neural stem cells (NSCs), require above all, a good survival of the graft. In this study, we unilaterally injected quinolinic acid (QA) into the striatum of adult mice and transplanted syngeneic NSCs of enhanced green fluorescent protein-transgenic mice into the lesioned striatum. The injection of QA leads to an excitotoxic lesion with selective cell death of the medium sized spiny neurons, the same cells that are affected in Huntington's disease. In order to investigate the best timing of transplantation for the survival of donor cells, we transplanted the stem cells at 2, 7 and 14 days after injury. In addition, the influence of graft preparation prior to transplantation, i.e., intact neurospheres versus dissociated cell suspension on graft survival was investigated. By far the best survival was found with the combination of early transplantation (i.e., 2 days after QA-lesion) with the use of neurospheres instead of dissociated cell suspension. This might be due to the different states of host's astrocytic and microglia activation which we found to be moderate at 2, but pronounced at 7 and 14 days after QA-lesion. We also investigated brain derived neurotrophic factor (BDNF)-expression in the striatum after QA-lesion and found no significant change in BDNF protein-level. We conclude that already the method of graft preparation of NSCs for transplantation, as well as the timing of the transplantation procedure strongly affects the survival of the donor cells when grafted into the QA-lesioned striatum of adult mice.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0014-4819
pubmed:author
pubmed:issnType
Print
pubmed:volume
177
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
458-70
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed-meshheading:17013619-Animals, pubmed-meshheading:17013619-Brain Tissue Transplantation, pubmed-meshheading:17013619-Brain-Derived Neurotrophic Factor, pubmed-meshheading:17013619-Cell Culture Techniques, pubmed-meshheading:17013619-Cell Survival, pubmed-meshheading:17013619-Cells, Cultured, pubmed-meshheading:17013619-Corpus Striatum, pubmed-meshheading:17013619-Denervation, pubmed-meshheading:17013619-Disease Models, Animal, pubmed-meshheading:17013619-Female, pubmed-meshheading:17013619-Gliosis, pubmed-meshheading:17013619-Graft Survival, pubmed-meshheading:17013619-Green Fluorescent Proteins, pubmed-meshheading:17013619-Huntington Disease, pubmed-meshheading:17013619-Male, pubmed-meshheading:17013619-Mice, pubmed-meshheading:17013619-Mice, Inbred C57BL, pubmed-meshheading:17013619-Mice, Transgenic, pubmed-meshheading:17013619-Neurons, pubmed-meshheading:17013619-Neurotoxins, pubmed-meshheading:17013619-Spheroids, Cellular, pubmed-meshheading:17013619-Stem Cell Transplantation, pubmed-meshheading:17013619-Stem Cells, pubmed-meshheading:17013619-Time Factors
pubmed:year
2007
pubmed:articleTitle
Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease.
pubmed:affiliation
Department of Neurology, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't